Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model
Year: 2023
Type: article
Abstract: Alzheimer’s disease (AD) is the most common neurodegenerative disorder and the No.1 cause of dementia in elderly with no effective treatments. 1 The application of stem cell-derived extracellular vesicles (EVs) has emerged as a promising therapeutic strategy for AD. 2 EVs are small bilipid layer-enclosed vesicles that display blood-brain barrier (BBB) penetrating ability and similar potency to their parental cells. 2 The administration of EVs derived from neural stem cells (NSCs) and mesenchymal stem cell (MSCs) improved learning and memory functions of AD mice after EVs injection. 2 NSC-derived EVs (NSC-EVs) have been reported to show better effects on improving neural recovery than MSC-derived EVs. 3 However, due to ethical/religious concerns, supply constraints, limited expandability in culture, genetic/phenotypic instability issues, and potential immune responses of allogenic cell secretomes, NSCs may not be an excellent cell source for the production of clinical-grade EVs. Our previous studies obtained mouse fibroblast-derived induced NSCs (iNSCs) through somatic cell reprogramming, opening a new window for obtaining EVs derived from NSC-like cells. 4 , 5 However, whether iNSC-derived (iNSC-EVs) can serve as promising substitutes of NSC-EVs in AD treatment remains unclear.
Institutions: Tongji University, Shanghai Sunshine Rehabilitation Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,190
OpenAlex ID: W4380538441
